Oral Inflammation/Ulcers

otezla 30mg single

Otezla Approved to Treat Oral Ulcers Associated With Behçet’s Disease

The Food and Drug Administration (FDA) has approved Otezla (apremilast; Celgene) for the treatment of adult patients with oral ulcers associated with Behçet’s disease. The approval was based on data from the placebo controlled, double blind phase 3 RELIEF study which evaluated the efficacy and safety of apremilast in patients with Behçet’s disease and active…

Could Tonsillectomy Qualifying Indicators Be More Lenient?

Researchers evaluating evidence for tonsillectomy found that more children would receive significant short-term improvement in their daily life if the current guidelines were relaxed. The two reviews were published online January 17 in Pediatrics